Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
European Journal of Neurology|April 10, 2021
Clinical and radiological activity of secondary progressive multiple sclerosis in a population-based cohortGuillaume Mathey, Thomas Ancel, Teresa Garot, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|February 6, 2008
Determination of interferon beta neutralizing antibodies in multiple sclerosis: improvement of clinical sensitivity of a cytopathic effect assayCatherine Massart, Jacqueline Gibassier, Jérôme de Seze, et al.Clinical Rehabilitation|June 2, 2020
Memory improvement in multiple sclerosis after an extensive cognitive rehabilitation program in groups with a multicenter double-blind randomized trialHelene Brissart, Abdou Y Omorou, Natacha Forthoffer, et al.Plos One|March 28, 2018
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational studyClotilde Nardin, Clotilde Latarche, Marc Soudant, et al.Journal of Neurology|July 4, 2020
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease InactivityAnne-Laure Kaminsky, Abdou Yacoubou Omorou, Marc Soudant, et al.Journal of Clinical Epidemiology|April 10, 2013
Item reduction based on rigorous methodological guidelines is necessary to maintain validity when shortening composite measurement scalesChristophe Goetz, Joël Coste, Fabienne Lemetayer, et al.Neurological Research|July 3, 2013
Cognitive impairment among different clinical courses of multiple sclerosisHelene Brissart, Elodie Morele, Cedric Baumann, et al.Frontiers in Neurology|December 7, 2017
Implementation and Evaluation of an Economic Model for Telestroke: Experience from <i>Virtuall</i>, FranceNolwenn Riou-Comte, Gioia Mione, Lisa Humbertjean, et al.Scientific Reports|December 8, 2016
Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarctionSébastien Richard, Vanessa Lapierre, Nicolas Girerd, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2008
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosisChristine Lebrun, Marc Debouverie, Patrick Vermersch, et al.Pageof 8